These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8193523)

  • 21. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
    Frishman WH; Sherman D; Feinfeld DA
    Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an LC-MS/MS method for determining the pharmacokinetics of clonidine following oral administration of Zhenju antihypertensive compound.
    Qin J; Wang L; Wu L; Chen J; Shen T; Li Y; Han L; Wang J
    Biomed Chromatogr; 2015 Jul; 29(7):1068-75. PubMed ID: 25516086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Cloniderm" toxicity: another manifestation of clonidine overdose.
    Killian CA; Roberge RJ; Krenzelok EP; Stonage CL
    Pediatr Emerg Care; 1997 Oct; 13(5):340-1. PubMed ID: 9368249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mini-tablet combination for sustained release of clonidine hydrochloride and hydrochlorothiazide: Preparation and pharmacokinetics in beagle dogs.
    Xu B; Wang Y; Zhu H
    Pharmazie; 2016 Feb; 71(2):76-83. PubMed ID: 27004371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine.
    Zawaideh MA; Duncan B; Joseph MW; Dixit MP
    Pediatr Nephrol; 2001 Jan; 16(1):85-6. PubMed ID: 11198612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.
    Ishii R; Furuta M; Hashimoto M; Tagawa T; Naruse T; Hata T
    Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
    Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
    Arndts D; Arndts K
    Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period.
    Segal IS; Jarvis DJ; Duncan SR; White PF; Maze M
    Anesthesiology; 1991 Feb; 74(2):220-5. PubMed ID: 1990896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal clonidine application: long-term results in essential hypertension.
    Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
    Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization of mice to topically applied drugs: albuterol, chlorpheniramine, clonidine and nadolol.
    Kalish R; Wood JA; Wille JJ; Kydonieus A
    Contact Dermatitis; 1996 Aug; 35(2):76-82. PubMed ID: 8917823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral substitution in patients sensitized by transdermal clonidine treatment.
    Maibach HI
    Contact Dermatitis; 1987 Jan; 16(1):1-8. PubMed ID: 3816202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal clonidine. Patching up errors.
    Cohen MR
    Nursing; 2003 Sep; 33(9):12. PubMed ID: 14562817
    [No Abstract]   [Full Text] [Related]  

  • 38. Transdermal and oral clonidine.
    Lilja M; Juustila H; Sarna S; Jounela AJ
    Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin depigmentation related to transdermal clonidine therapy.
    Doe N; Seth S; Hebert LA
    Arch Intern Med; 1995 Oct; 155(19):2129. PubMed ID: 7575076
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.